Impact of circulating tumor DNA (ctDNA) surveillance on clinical care for patients with stage I-III breast cancer: Findings from a multi-ins Published Date September 22, 2026 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen
